Topic

Retevmo (selpercatinib)

A collection of 19 issues

How to Get Retevmo (Selpercatinib) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Cigna in Washington Cigna requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and RET-altered thyroid cancers. Key requirements: FDA-approved RET test results, advanced/metastatic disease documentation, and NCCN-aligned medical necessity. If denied, Washington residents can use internal appeals (180-day deadline) followed

How to Get Retevmo (Selpercatinib) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by Humana in New York Retevmo (selpercatinib) requires prior authorization under Humana Medicare plans and may be non-formulary depending on your specific plan. To get coverage in New York: 1) Have your oncologist submit a prior authorization request with RET mutation testing results and medical

Myths vs. Facts: Getting Retevmo (Selpercatinib) Covered by UnitedHealthcare in California

Answer Box: Getting Retevmo Covered by UnitedHealthcare in California The fastest path to Retevmo approval: Submit prior authorization with FDA-approved RET testing results, complete treatment history, and clinical necessity documentation. If denied, file an expedited internal appeal within 21 days, then request California DMHC Independent Medical Review (73% success rate)

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and thyroid cancers. You'll need FDA-approved RET testing results, pathology reports, and clinical documentation. If denied, file internal appeals within 180 days,

How to Get Retevmo (Selpercatinib) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Humana in Illinois Retevmo requires prior authorization from Humana and is typically non-formulary, requiring a formulary exception request. The fastest path to approval: 1) Confirm RET alteration with FDA-approved genetic testing, 2) Have your oncologist submit a comprehensive prior authorization through Humana'

How to Get Retevmo (selpercatinib) Covered by Cigna in Ohio: Complete Prior Authorization and Appeal Guide

Answer Box: Fastest Path to Retevmo Coverage Cigna requires prior authorization for Retevmo (selpercatinib) in Ohio. Your oncologist must submit documentation proving RET gene alteration via FDA-approved testing (like FoundationOne CDx), diagnosis of RET fusion-positive NSCLC or RET-mutant thyroid cancer, and prior treatment history. Submit through Cigna's provider

Get Retevmo (Selpercatinib) Approved by Aetna CVS Health in California: Complete Guide to Prior Authorization, Appeals & Timeline

Answer Box: Your Fastest Path to Retevmo Coverage Retevmo (selpercatinib) requires prior authorization from Aetna CVS Health in California. To get approved fastest: (1) Ensure RET alteration testing via FDA-approved methods like FoundationOne CDx is documented, (2) Have your oncologist submit the PA with complete clinical records through CVS Specialty&

How Long Does It Take to Get Retevmo (selpercatinib) Approved by Aetna (CVS Health) in Florida? Timeline & Milestones

Answer Box: What to Expect Getting Retevmo (selpercatinib) approved by Aetna (CVS Health) in Florida typically takes 14 calendar days for standard prior authorization, or 72 hours for expedited requests. The process requires documented RET alteration testing via FDA-approved companion diagnostics, complete clinical records, and submission through CVS Specialty Pharmacy.

How to Get Retevmo (Selpercatinib) Covered by Aetna in Washington: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Retevmo Covered by Aetna in Washington Aetna requires prior authorization for Retevmo (selpercatinib), with documentation of RET fusion testing and step therapy compliance. Most approvals take 72 hours with complete documentation. If denied, you have 60 days to appeal internally, then can request external review through Washington&

Blue Cross Blue Shield of Michigan's Coverage Criteria for Retevmo (Selpercatinib): Complete Prior Authorization and Appeal Guide

Answer Box: Getting Retevmo Covered by BCBSM Fastest path to approval: Submit prior authorization with FDA-approved RET fusion test results, documented treatment history, baseline ECG showing QTc <500ms, and a detailed medical necessity letter citing FDA labeling. First step today: Contact BCBSM member services at the number on your